Premium
Valuing cure: Bridging cost‐effectiveness and coverage decisions for hepatitis C therapy
Author(s) -
Pho Mai T.,
Linas Benjamin P.
Publication year - 2014
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.27220
Subject(s) - simeprevir , medicine , sofosbuvir , hepatology , hepatitis c , intensive care medicine , cost effectiveness , hepatitis c virus , immunology , virus , ribavirin , risk analysis (engineering)